Apollomics, Inc. (NASDAQ:APLMW) Short Interest Down 42.4% in July

Apollomics, Inc. (NASDAQ:APLMW) was the recipient of a significant decline in short interest in the month of July. As of July 31st, there was short interest totalling 19,300 shares, a decline of 42.4% from the July 15th total of 33,500 shares. Based on an average daily volume of 16,200 shares, the days-to-cover ratio is presently 1.2 days.

Apollomics Stock Down 0.7 %

Shares of NASDAQ APLMW traded down $0.00 during trading on Wednesday, hitting $0.01. 1,130 shares of the company traded hands, compared to its average volume of 24,575. The company has a 50-day moving average price of $0.01 and a 200-day moving average price of $0.02. Apollomics has a 1 year low of $0.01 and a 1 year high of $0.10.

About Apollomics

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.